Educating officials regarding a diagnostic tool applicable for field use.
Educating officials regarding a diagnostic tool.
Educating officials about a health care diagnostic tool applicable to public health and security.
Educating officials about a health care diagnostic tool.
Educating officials about a health care diagnostic tool usable for agricultural and livestock diagnostics.
Duration: December 16, 2016
to
December 31, 2021
General Issues: Defense , Health Issues , Homeland Security , Medical/Disease Research/Clinical Labs , Agriculture , Disaster Planning/Emergencies , Animals
Spending: about $225,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2016: U.S. Senate, House of Representatives, Defense - Dept of (DOD), Homeland Security - Dept of (DHS), Agriculture - Dept of (USDA)
Related Foreign Entities:
BioPorto Diagnostics (Hellerup, DEN); contribution to lobbying: $500; ownership 100%
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2021
In Q4, Ott Bielitzki & O'Neill PLLC did no lobbying for BioPorto Diagnostics A/S . The report was filed on Jan. 18, 2022.
Original Filing: 301324626.xml
4th Quarter, 2021
Ott Bielitzki & O'Neill PLLC terminated an engagement in which they represented BioPorto Diagnostics A/S on Jan. 18, 2022.
Original Filing: 301324627.xml
3rd Quarter, 2021
In Q3, Ott Bielitzki & O'Neill PLLC did no lobbying for BioPorto Diagnostics A/S . The report was filed on Nov. 3, 2021.
Original Filing: 301316976.xml
2nd Quarter, 2021
In Q2, Ott Bielitzki & O'Neill PLLC did no lobbying for BioPorto Diagnostics A/S . The report was filed on Aug. 26, 2021.
Original Filing: 301294775.xml
1st Quarter, 2021
In Q1, Ott Bielitzki & O'Neill PLLC did no lobbying for BioPorto Diagnostics A/S . The report was filed on April 6, 2021.
Original Filing: 301250828.xml
4th Quarter, 2020
In Q4, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S . The report was filed on Feb. 17, 2021.
Original Filing: 301248624.xml
Lobbying Issues
Educating officials regarding a diagnostic tool applicable for field use.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials regarding a diagnostic tool.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool applicable to public health and security.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educating officials about a health care diagnostic tool usable for agricultural and livestock diagnostics.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on Nov. 17, 2020.
Original Filing: 301226862.xml
Lobbying Issues
Educating officials regarding a diagnostic tool applicable for field use.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials regarding a diagnostic tool.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool applicable to public health and security.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educating officials about a health care diagnostic tool usable for agricultural and livestock diagnostics.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on July 1, 2020.
Original Filing: 301184958.xml
Lobbying Issues
Educating officials regarding a diagnostic tool applicable for field use.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials regarding a diagnostic tool.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool applicable to public health and security.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educating officials about a health care diagnostic tool usable for agricultural and livestock diagnostics.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on May 6, 2020.
Original Filing: 301182276.xml
Lobbying Issues
Educating officials regarding a diagnostic tool applicable for field use.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials regarding a diagnostic tool.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool applicable to public health and security.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educating officials about a health care diagnostic tool usable for agricultural and livestock diagnostics.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on Jan. 6, 2020.
Original Filing: 301103333.xml
Lobbying Issues
Educating officials regarding a diagnostic tool applicable for field use.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials regarding a diagnostic tool.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool applicable to public health and security.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educating officials about a health care diagnostic tool usable for agricultural and livestock diagnostics.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on Oct. 10, 2019.
Original Filing: 301064312.xml
Lobbying Issues
Educating officials regarding a diagnostic tool applicable for field use.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials regarding a diagnostic tool.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool applicable to public health and security.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educating officials about a health care diagnostic tool usable for agricultural and livestock diagnostics.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on July 6, 2019.
Original Filing: 301043378.xml
Lobbying Issues
Educating officials regarding a diagnostic tool applicable for field use.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials regarding a diagnostic tool.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool applicable to public health and security.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educating officials about a health care diagnostic tool usable for agricultural and livestock diagnostics.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on April 1, 2019.
Original Filing: 301022109.xml
Lobbying Issues
Educating officials regarding a diagnostic tool applicable for field use.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials regarding a diagnostic tool.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool applicable to public health and security.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Educating officials about a health care diagnostic tool.
Agencies Lobbied
U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Educating officials about a health care diagnostic tool usable for agricultural and livestock diagnostics.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on Jan. 7, 2019.
Original Filing: 301002563.xml
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on Oct. 1, 2018.
Original Filing: 300982325.xml
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on July 2, 2018.
Original Filing: 300961854.xml
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
Ott Bielitzki & O'Neill PLLC amended a lobbying report for representation of BioPorto Diagnostics A/S in Q12018 on June 1, 2018.
Original Filing: 300961002.xml
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on April 25, 2018.
Original Filing: 300959097.xml
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on Jan. 10, 2018.
Original Filing: 300922337.xml
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on Oct. 26, 2017.
Original Filing: 300917764.xml
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Disease Research/Clinical Labs
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on Aug. 2, 2017.
Original Filing: 300899013.xml
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Defense/Disease Research/Clinical Labs
1st Quarter, 2017
In Q1, Ott Bielitzki & O'Neill PLLC lobbied for BioPorto Diagnostics A/S , earning $15,000. The report was filed on April 24, 2017.
Original Filing: 300878925.xml
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
BioPorto develops diagnostic tests and tools that can be used to quickly and effectively diagnose diseases in humans, plants and animals.
Agencies Lobbied
U.S. Senate
Type of Issue
Defense/Disease Research/Clinical Labs
4th Quarter, 2016
Ott Bielitzki & O'Neill PLLC filed a lobbying registration on April 18, 2017 to represent BioPorto Diagnostics A/S, effective Dec. 16, 2016.
Original Filing: 300867452.xml
Issue(s) they said they’d lobby about: Client develops diagnostic tools and kits that may be useful for human, animal and plant disease detection. Potential application for emergency response and detection of disease outbreaks. .
1st Quarter, 2016
In Q1, Ott Bielitzki & O'Neill PLLC did no lobbying for BioPorto Diagnostics A/S . The report was filed on July 18, 2017.
Original Filing: 300887787.xml
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...